MedTrace Logo

The Norwegian Vitamin Trial (NORVIT)

NCT00266487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3750

Last updated 2017-05-08

No results posted yet for this study

Summary

The purpose of this study is to examine whether the lowering of blood homocysteine levels by treatment with B vitamins can prevent cardiovascular disease

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

Folic acid

DRUG

Vitamin B12

DRUG

Vitamin B6

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER

  • The Council on Health and Rehabilitation, Norway

    collaborator UNKNOWN

  • The Norwegian Council on Cardiovascular Disease

    collaborator UNKNOWN

  • The Royal Norwegian Ministry of Health

    collaborator OTHER

  • The International Federation of Red Cross and Red Crescent Societies

    collaborator OTHER

  • Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway

    collaborator OTHER

  • University of Tromso

    lead OTHER

Principal Investigators

  • Kaare H Bonaa, M.D., Ph.D · Institute of Community Medicine, University of Tromsø, Norway

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-12-31
Completion
2004-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00266487 on ClinicalTrials.gov